Navigation Links
Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
Date:1/4/2008

paedic surgeries such as hip and knee replacement, bunionectomy, open fracture repair and certain bone graft procedures. Detailed market research performed independently by L.E.K. Consulting has predicted peak US sales of BUPIVACAINE SURGICAL IMPLANT nearing $310 million.

"This first dosing with our Bupivacaine Implant for the management of post-operative pain follows hot on the heels of other phase 2 and phase 3 trials recently initiated with our topically-applied Gentamicin-Collagen sponge for the treatment of infected diabetic foot ulcers and our Gentamicin Surgical Implant for the prevention of surgical site infection. This certainly marks a very exciting time for Innocoll as we embark upon the dosing of patients in three clinical trials for different products spanning three different therapeutic categories", said Dr. Michael Myers, Innocoll's President and CEO.

About Innocoll, Inc.

Innocoll is a privately held, specialty pharmaceutical company focused on biodegradable surgical implants and topically applied healthcare products. It develops and manufactures a range of pharmaceutical products and medical devices using its proprietary collagen-based technologies, CollaRx(R) and Liquicoll(R). Innocoll 's lead product, GENTAMICIN SURGICAL IMPLANT, for the treatment and prevention of surgical site infections, is approved for sale in 49 countries in Europe, Latin America, Middle East, Africa and Asia and is marketed under the following trade names; COLLATAMP(R) G, COLLATAMP(R) EG, SULMYCIN(R) IMPLANT, GARAMYCIN(R) SCHWAMM, DURACOL(R), DURACOLL(R), GENTACOL(R), GENTACOLL(R), GARACOL(R), GARACOLL(R), and CRONOCOL(R). In 2005, Innocoll acquired the worldwide marketing rights for this product from Essex Chemis AG, an affiliated company of Schering-Plough Corporation (NYSE:

SOURCE Innocoll Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
2. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
3. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... DIEGO and WALTHAM, Mass., July 29, 2015 ... is investigating whether certain officers and ... their fiduciary duties to shareholders.  AMAG Pharmaceuticals operates ... maternal health, anemia, and cancer supportive care.  The ... reduce the risk of preterm birth in women ...
(Date:7/29/2015)... Heska Corporation (NASDAQ: HSKA - News; ... diagnostic and other specialty veterinary products , today reported financial ... Second Quarter 2015 Highlights with Prior Year Comparison: ... $1.829 million, from $917 thousand. , Blood Analyzer and ... , Core Companion Animal revenue was up 19% to ...
(Date:7/29/2015)... 2015 The Judicial Panel on Multidistrict Litigation ... to centralize Inferior vena cava (IVC) Filter lawsuits filed ... Medical, have already been centralized by the JPML. ... at risk for a pulmonary embolism. The filters are ... lungs. Claims against Bard and Cook involve incidents of ...
Breaking Medicine Technology:Robbins Arroyo LLP Is Investigating the Officers and Directors of AMAG Pharmaceuticals, Inc. (AMAG) on Behalf of Shareholders 2Heska Reports Financial Results for the Second Quarter of 2015 2Heska Reports Financial Results for the Second Quarter of 2015 3Heska Reports Financial Results for the Second Quarter of 2015 4Heska Reports Financial Results for the Second Quarter of 2015 5Heska Reports Financial Results for the Second Quarter of 2015 6Heska Reports Financial Results for the Second Quarter of 2015 7Heska Reports Financial Results for the Second Quarter of 2015 8IVC filter litigation continues; law firm provides free information to IVC filter patients 2
(Date:7/29/2015)... , ... July 29, 2015 , ... Avatar Solutions has ... Systems (CAHPS) for PQRS Survey. , The CAHPS for PQRS Survey collects ... of 100 or more eligible providers must participate or they will receive a 2% ...
(Date:7/29/2015)... ... July 29, 2015 , ... In an ... with the problems of substance abuse that face today’s society, A Forever Recovery ... come to their rehabilitation center. The facility, located in Southwest Michigan hosted a ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Conventional theories ... and trade goods and services may be able to unlock mysteries about the behavior ... Graduate University , Boston University, and Columbia University. , The findings, published July 29 ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... production, announced today that Columbia University Medical Center, located in New York, NY, ... studio makes it easy for physicians and scientists to immediately access worldwide TV ...
(Date:7/29/2015)... ... July 29, 2015 , ... Abt ... within Abt’s U.S. Health division. In her position, Ramkeesoon will help build ... to joining Abt, Ramkeesoon spent close to a decade at ICF International, most ...
Breaking Medicine News(10 mins):Health News:Avatar Solutions Approved to Administer CAHPS for Physician Quality Reporting System (PQRS) 2Health News:Avatar Solutions Approved to Administer CAHPS for Physician Quality Reporting System (PQRS) 3Health News:MADD Victim Services Specialist Visits A Forever Recovery Rehabilitation Facility 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 3Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 2Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 3Health News:Selena Ramkeesoon Joins Abt Associates as Vice President for Strategic Communications 2
... largest meat processor, Maple Leaf Foods, on Tuesday decided to ... of its meat // products with an unknown contaminant. ... when Maple Leaf Employees found syringe casings at the company's ... Federal agency and CFIA's food safety officer, Garfield Balsom took ...
... World Ayurveda Congress at the University of Pune on ... Anbumani Ramadoss, //announced a series of steps to be ... India and abroad. He said, 'In a scenario where ... India’s rich tradition needed to be tapped and packaged ...
... wonder then, that the University of Queensland, Queensland ... David Fleay's Wildlife Park and the Zoological Society ... interesting project. The combined project is an artificial ... Monday and scientists believe the technique can be ...
... filed an appeal with the Pakistan Cricket Board (PCB) to ... tribunal on Nov 1.// ,Shoaib handed over the ... newspaper Wednesday quoted the PCB spokesperson as saying. ,Another ... ban by the same doping tribunal, filed his appeal to ...
... study that by actually allowing a stream of mild electrical ... stimulate a person’s mind helping him definitely to clearly recall ... ordinarily be able to do. ,Neuroscientist Lisa Marshall of ... found that applying electrical stimuli to the brain scalp which ...
... hearted - there is a 1 in 300 chance of dying ... England Sir Liam Donaldson has said in a cautionary message . ... WHO's campaign on the need for hospitals to address hygiene issues ... the chances of dying in an aircrash hollow , where the ...
Cached Medicine News:Health News:Government Announces Steps To Promote Ayurvedic Medicine 2
The base of the staple is round and threaded to enable screwing onto the stapler. The base also has spikes. The legs of the staple are contoured to prevent the staple from backing out....
... Cement consists of a two ... bone cement liquid within a ... polyethylene bag,containing bone cement powder ... interiors of the blister pack,and ...
... ORTHOSET Radiopaque Bone Cement ... system: a sterile,ampule containing bone ... pack, and a sterile polyethylene ... a peelable pouch. The interiors ...
A "doughy" type of bone cement intended for manual application....
Medicine Products: